Gould & Ratner, with Fred Tannenbaum as lead partner, and with the help of Ammara Khan and Julie Gracz, recently represented client, EternaTear, developer of a next-generation, over-the-counter (OTC), preservative-free artificial tear for dry eye sufferers, announced today it has completed its oversubscribed Series A round of financing. EternaTear is developing a novel artificial tear formulation designed to supplement all layers of the eye’s tear film, thereby providing relief from dry eye more effectively than currently marketed products.

Read more here.